Piet Postmus


1990 …2019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Thunnissen, E., Lissenberg-Witte, B. I., van den Heuvel, M. M., Monkhorst, K., Skov, B. G., Sørensen, J. B., Mellemgaard, A., Dingemans, A. M. C., Speel, E. J. M., de Langen, A. J., Hashemi, S. M. S., Bahce, I., van der Drift, M. A., Looijen-Salamon, M. G., Gosney, J., Postmus, P. E., Samii, S. M. S., Duplaquet, F., Weynand, B., Durando, X. & 15 othersPenault-Llorca, F., Finn, S., Grady, A. O., Oz, B., Akyurek, N., Buettner, R., Wolf, J., Bubendorf, L., Duin, S., Marondel, I., Heukamp, L. C., Timens, W., Schuuring, E. M. D., Pauwels, P. & Smit, E. F., 2019, In : Lung Cancer. 138, p. 13-18 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Association between depth of response and survival in patients with advanced-stage non–small cell lung cancer treated with first-line chemotherapy

Morgensztern, D., Ko, A., O’Brien, M., Ong, T. J., Waqar, S. N., Socinski, M. A., Postmus, P. E. & Bhore, R., 15 Jul 2019, In : Cancer. 125, 14, p. 2394-2399

Research output: Contribution to journalArticleAcademicpeer-review

Brain metastases: Costs for care need to be spend more effectively!

Postmus, P. E., 1 Apr 2019, In : Annals of Palliative Medicine. 8, 2, p. 207-209

Research output: Contribution to journalEditorialAcademicpeer-review

Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report

Dingemans, A-M. C., Hendriks, L. E. L., Berghmans, T., Levy, A., Hasan, B., Faivre-Finn, C., Giaj-Levra, M., Giaj-Levra, N., Girard, N., Greillier, L., Lantuéjoul, S., Edwards, J., O'Brien, M., Reck, M., Smit, E. F., Van Schil, P., Postmus, P. E., Ramella, S., Lievens, Y., Gaga, M. & 18 othersPeled, N., Scagliotti, G. V., Senan, S., Paz-Ares, L., Guckenberger, M., McDonald, F., Ekman, S., Cufer, T., Gietema, H., Infante, M., Dziadziuszko, R., Peters, S., Porta, R. R., Vansteenkiste, J., Dooms, C., de Ruysscher, D., Besse, B. & Novello, S., 1 Dec 2019, In : Journal of Thoracic Oncology. 14, 12, p. 2109-2119 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study

Cho, B. C., Obermannova, R., Bearz, A., McKeage, M., Kim, D-W., Batra, U., Borra, G., Orlov, S., Kim, S-W., Geater, S. L., Postmus, P. E., Laurie, S. A., Park, K., Yang, C-T., Ardizzoni, A., Bettini, A. C., de Castro, G., Kiertsman, F., Chen, Z., Lau, Y. Y. & 3 othersViraswami-Appanna, K., Passos, V. Q. & Dziadziuszko, R., 1 Jul 2019, In : Journal of Thoracic Oncology. 14, 7, p. 1255-1265 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access